Entries tagged "pharma"
There's been quite a bit of M&A activity in the pharma world lately. What companies within the sector will likely be the next to be acquired?
The health sector passed a curious milestone: For the first time venture funding of life sciences topped information technology investments.
Speculation about a Pfizer Inc. deal for Wyeth, first reported in Friday's Wall Street Journal, raises an age-old question that applies to more than just the pharmaceutical industry: size, its merits and demerits. Over the past decade or so, Pfizer has steadily built itself through acquisitions into a behemoth, and the Wyeth deal would push it to $75 billion in revenues. The argument for consolidation and great size has several parts, some obvious, some not. ...
The fire sale continues at PDL BioPharma Inc. as the biotech company unloaded yet another asset Thursday, selling its antibody manufacturing facility to Danish biotechnology company Genmab A/S for $240 million. ...
After sucessfully consolidating the health insurance industry over a 15-year tenure, UnitedHealth Group Inc.'s longtime CEO and chairman, William McGuire, agreed to step down by Dec. 1 because of his involvement in back-dating options. While McGuire falls on his sword, the company's CFO, Stephen Hemsley, will take the helm, even though he also participated in the fraudulent activity. Under McGuire's tutelage, the company became the largest health insurer in the country thanks in part to an active acquisition effort. Over the last five years, the company has made seven acquisitions worth a staggering $17.8 billion. The largest deal was last...
